Table 3.

Relationship of HbA1c levels at baseline and 3-months with final TB treatment outcomes

Outcome of TB treatment	Patients with HbA1c level at baseline and 3-months*				p-value
	Normal-Normal	Normal–Elevated	Elevated-Normal	Elevated-Elevated
Number of patients	67	5	49	37
Number (%) with treatment success	64 (95.5%)	5 (100%)	46 (93.9%)	35 (94.6%)	0.97
Number (%) failing treatment	2 (3%)	0	1 (2%)	1 (2.7%)
Number (%) lost to follow-up (defaulted)	0	0	1 (2%)	0
Number (%) who died	1 (1.5%)	0	1 (2%)	1 (2.7%)

*Normal level of HbA1c is considered less than 6.5% and elevated level is considered more than 6.5%.

Abbreviations: TB tuberculosis, HbA1c Glycosylated haemoglobin, SD Standard deviation, HIV human immunodeficiency virus, FBG Fasting blood glucose.